Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects
Crossref DOI link: https://doi.org/10.1007/s00280-017-3480-9
Published Online: 2017-11-29
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gerisch, Michael
Hafner, Frank-Thorsten
Lang, Dieter
Radtke, Martin
Diefenbach, Konstanze
Cleton, Adriaan
Lettieri, John
Funding for this research was provided by:
Bayer
License valid from 2017-11-29